Difficulty: Medium
Average Score: 90%
Practice
During treatment with reteplase (Retavase) for a patient with a STEMI, which finding should most concern the nurse?
Correct answer
A
Rationale
In this scenario, the correct answer is option A: Oozing of blood from the IV site. When a patient with a STEMI is receiving reteplase, a thrombolytic medication, one of the complications to watch out for is bleeding due to its anticoagulant effects. Oozing from the IV site indicates that the patient may be experiencing excessive bleeding, which can lead to serious complications such as hemorrhage.
Option B, a BP of 102/60 mm Hg with an HR of 78 bpm, is within normal range and not a concerning finding in this context.
Option C, a decrease in the responsiveness of the patient, could be a sign of various issues but is not specifically related to reteplase administration.
Option D, the presence of intermittent accelerated idioventricular dysrhythmias, could be a concern but is not the most immediate concern when a patient is being treated with reteplase, as bleeding complications take precedence.
Educationally, it is crucial for nurses to understand the potential side effects and complications of medications used in the treatment of STEMI. Monitoring for adverse effects, such as bleeding, is essential to ensure patient safety and well-being. Nurses must be vigilant in assessing and managing these potential complications to provide effective and safe care to patients undergoing thrombolytic therapy.
Option B, a BP of 102/60 mm Hg with an HR of 78 bpm, is within normal range and not a concerning finding in this context.
Option C, a decrease in the responsiveness of the patient, could be a sign of various issues but is not specifically related to reteplase administration.
Option D, the presence of intermittent accelerated idioventricular dysrhythmias, could be a concern but is not the most immediate concern when a patient is being treated with reteplase, as bleeding complications take precedence.
Educationally, it is crucial for nurses to understand the potential side effects and complications of medications used in the treatment of STEMI. Monitoring for adverse effects, such as bleeding, is essential to ensure patient safety and well-being. Nurses must be vigilant in assessing and managing these potential complications to provide effective and safe care to patients undergoing thrombolytic therapy.